Algorithm reduces use of riskier antibiotics for UTIs
Machine learning model predicts probability that a particular urinary tract infection can be treated by specific antibiotics.
3 Questions: Ram Sasisekharan on hastening vaccines and treatments
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
Regina Barzilay wins $1M Association for the Advancement of Artificial Intelligence Squirrel AI award
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.
Making tuberculosis more susceptible to antibiotics
Shortening carbohydrates in the bacterial cell wall makes them more vulnerable to certain drugs.
A new way to make bacteria more sensitive to antibiotics
SMART researchers find exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.
How often do vaccine trials hit paydirt?
Study: Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.
SMART researchers uncover new anti-phage defense mechanisms
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
Jim Collins receives funding to harness AI for drug discovery
The Audacious Project commitment will support the development of new classes of antibiotics to treat the world’s deadliest bacterial pathogens.
Professor Emeritus Arnold Demain, a pioneer in the development of antibiotics, dies at 92
An eminent microbiologist, Demain conducted groundbreaking antibiotics research and mentored hundreds of young scientists.
SMART announces new method for processing fluid droplets
Microfluidics enables researchers to create unique environment for developing medicine, paving the way for more potent, high-quality drugs.
The new front against antibiotic resistance
Deborah Hung shares research strategies to combat tuberculosis as part of the Department of Biology's IAP seminar series on microbes in health and disease.
SMART and NTU researchers design polymer that can kill drug-resistant bacteria
Polymer may pave the way for drugs to which bacteria are significantly less resistant, a breakthrough that could save hundreds of thousands of lives per year.
Engineered viruses could fight drug resistance
By tweaking bacteriophage genomes, MIT team creates a new weapon to combat infection.
The complex world of carbohydrate chemistry
Drawn to MIT by its “amazing women who were doing science,” Professor Laura Kiessling explores sugar-protein interactions that influence cell behavior.
MIT engineers repurpose wasp venom as an antibiotic drug
Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.